Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3466)
All Articles published online
|
Jan 14, 2011 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kuiper P, Hawinkels LJ, Jonge-Muller ES, Biemond I, Lamers CB, Verspaget HW. Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2011; 17(2): 219-225 [PMID: 21245995 DOI: 10.3748/wjg.v17.i2.219] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i2/219.htm |
| Number | Citing Articles |
| 1 |
David L. Chan, Eva Segelov, Simron Singh. Neuroendocrine Tumors in Real Life. 2018; : 305 doi: 10.1007/978-3-319-59024-0_22
|
| 2 |
Omar Abdel-Rahman. Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations. Tumor Biology 2014; 35(11): 10615 doi: 10.1007/s13277-014-2612-7
|
| 3 |
Florian Bösch, Annelore Altendorf-Hofmann, Sven Jacob, Christoph J. Auernhammer, Christine Spitzweg, Stefan Boeck, Gabriele Schubert-Fritschle, Jens Werner, Thomas Kirchner, Martin K. Angele, Thomas Knösel. Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor. Journal of Clinical Medicine 2020; 9(10): 3368 doi: 10.3390/jcm9103368
|
| 4 |
Elena Núñez-Gómez, Miguel Pericacho, Claudia Ollauri-Ibáñez, Carmelo Bernabéu, José M. López-Novoa. The role of endoglin in post-ischemic revascularization. Angiogenesis 2017; 20(1): 1 doi: 10.1007/s10456-016-9535-4
|
| 5 |
Elisa Rossi, Céline Goyard, Audrey Cras, Blandine Dizier, Nour Bacha, Anna Lokajczyk, Coralie Guerin, Nicolas Gendron, Benjamin Planquette, Virginie Mignon, Carmelo Bernabeu, Olivier Sanchez, David Smadja. Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism. Thrombosis and Haemostasis 2017; 117(10): 1908 doi: 10.1160/TH17-01-0007
|
| 6 |
Liangtao Ye, Huilin Ye, Quanbo Zhou, Zhihua Li, Qing Lin, Langping Tan, Wenchao Gao, Zhiqiang Fu, Shangyou Zheng, Rufu Chen. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases. International Journal of Surgery 2016; 29: 108 doi: 10.1016/j.ijsu.2016.03.036
|
| 7 |
Dao-Hui Yang, Juan Cheng, Xiao-Fan Tian, Qi Zhang, Ling-Yun Yu, Yi-Jie Qiu, Xiu-Yun Lu, Wen-Hui Lou, Yi Dong, Wen-Ping Wang. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis. Diagnostics 2023; 13(2): 238 doi: 10.3390/diagnostics13020238
|
| 8 |
Saimon Takada, Hironari Kato, Yosuke Saragai, Shinichiro Muro, Daisuke Uchida, Takeshi Tomoda, Kazuyuki Matsumoto, Shigeru Horiguchi, Noriyuki Tanaka, Hiroyuki Okada. Contrast-enhanced harmonic endoscopic ultrasound using time–intensity curve analysis predicts pathological grade of pancreatic neuroendocrine neoplasm. Journal of Medical Ultrasonics 2019; 46(4): 449 doi: 10.1007/s10396-019-00967-x
|
| 9 |
Omar Abdel-Rahman, Mona Fouad. Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature. Journal of Cancer Research and Clinical Oncology 2015; 141(2): 295 doi: 10.1007/s00432-014-1757-5
|
| 10 |
Amr Mohamed, Asfar S. Azmi, Sylvia L. Asa, Sree Harsha Tirumani, Amit Mahipal, Sakti Cjakrabarti, David Bajor, J. Eva Selfridge, Ahmed O. Kaseb. Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination. Current Oncology 2022; 29(11): 9018 doi: 10.3390/curroncol29110707
|
| 11 |
Jesús Tejero, Pilar Jiménez, Emiliano Quinto, Damián Cordoba-Diaz, Manuel Garrosa, Manuel Cordoba-Diaz, Manuel Gayoso, Tomás Girbés. Elderberries: A Source of Ribosome-Inactivating Proteins with Lectin Activity. Molecules 2015; 20(2): 2364 doi: 10.3390/molecules20022364
|
| 12 |
Liangjing Zhou, Leilai Yu, Guoping Ding, Wenchao Chen, Sixin Zheng, Liping Cao. Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Pathology & Oncology Research 2015; 21(4): 1141 doi: 10.1007/s12253-015-9937-4
|
| 13 |
Federica Grillo, Tullio Florio, Francesco Ferraù, Elda Kara, Giuseppe Fanciulli, Antongiulio Faggiano, Annamaria Colao, _ _. Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms. Endocrine-Related Cancer 2018; 25(9): R453 doi: 10.1530/ERC-17-0531
|
| 14 |
Marcos Vinícius Macedo de Oliveira, Carlos Alberto de Carvalho Fraga, Lucas Oliveira Barros, Camila Santos Pereira, Sérgio Henrique Sousa Santos, John R. Basile, Ricardo Santiago Gomez, André Luiz Sena Guimarães, Alfredo Maurício Batista De-Paula. High expression of S100A4 and endoglin is associated with metastatic disease in head and neck squamous cell carcinoma. Clinical & Experimental Metastasis 2014; 31(6): 639 doi: 10.1007/s10585-014-9655-4
|
| 15 |
José M. Ferreras, Lucía Citores, Rosario Iglesias, Pilar Jiménez, Tomás Girbés. Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy. Toxins 2011; 3(5): 420 doi: 10.3390/toxins3050420
|
| 16 |
Chiara Alessandra Cella, Saverio Minucci, Francesca Spada, Salvatore Galdy, Mohamed Elgendy, Paola Simona Ravenda, Maria Giulia Zampino, Sabina Murgioni, Nicola Fazio. Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: From bench to bedside. Cancer Treatment Reviews 2015; 41(9): 754 doi: 10.1016/j.ctrv.2015.06.008
|
| 17 |
Yoichiro Okubo, Osamu Motohashi, Norisuke Nakayama, Ken Nishimura, Rika Kasajima, Yohei Miyagi, Manabu Shiozawa, Emi Yoshioka, Masaki Suzuki, Kota Washimi, Kae Kawachi, Madoka Nito, Yoichi Kameda, Tomoyuki Yokose. The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure. Diagnostic Pathology 2016; 11(1) doi: 10.1186/s13000-016-0580-5
|
| 18 |
D J Pinato, T M Tan, S T K Toussi, R Ramachandran, N Martin, K Meeran, N Ngo, R Dina, R Sharma. An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes. British Journal of Cancer 2014; 110(1): 115 doi: 10.1038/bjc.2013.682
|
| 19 |
Omar Abdel-Rahman, Mona Fouad. Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data. Tumor Biology 2015; 36(2): 467 doi: 10.1007/s13277-015-3064-4
|
| 20 |
Xiaofan Guo, Song Gao, Zekun Li, Jihui Hao. The role of biomarker in pancreatic neuroendocrine tumor: a narrative review. Journal of Pancreatology 2021; 4(3): 122 doi: 10.1097/JP9.0000000000000076
|
| 21 |
Rossana Berardi, Mariangela Torniai, Stefano Partelli, Corrado Rubini, Silvia Pagliaretta, Agnese Savini, Vanessa Polenta, Matteo Santoni, Riccardo Giampieri, Sofia Onorati, Federica Barucca, Alberto Murrone, Francesca Bianchi, Massimo Falconi, Daotai Nie. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms. PLOS ONE 2018; 13(5): e0197035 doi: 10.1371/journal.pone.0197035
|
| 22 |
Claudia Ollauri-Ibáñez, José M López-Novoa, Miguel Pericacho. Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies. Expert Opinion on Biological Therapy 2017; 17(9): 1053 doi: 10.1080/14712598.2017.1346607
|
| 23 |
Wensheng Deng, Ming Duan, Binbin Qian, Yiming Zhu, Jiayun Lin, Lei Zheng, Chihao Zhang, Xiaoliang Qi, Meng Luo. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3): 255 doi: 10.1016/j.clinre.2018.10.004
|
| 24 |
María del Pilar Pérez Rodríguez, Claudia Alarcón-Torrecillas, Miguel Pericacho, Iván Rodríguez-Escolar, Elena Carretón, Rodrigo Morchón. Effect of somatic antigens of Dirofilaria repens adult worms on angiogenesis, cell proliferation and migration and pseudo-capillary formation in human endothelial cells. Parasites & Vectors 2023; 16(1) doi: 10.1186/s13071-023-05726-z
|